Suppr超能文献

使用持续葡萄糖监测的糖尿病患者的血糖在目标范围内的时间与妊娠结局

Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring.

作者信息

Fishel Bartal Michal, Ashby Cornthwaite Joycelyn A, Ghafir Danna, Ward Clara, Ortiz Gladys, Louis Aleaha, Cornthwaite John, Chauhan Suneet S P, Sibai Baha M

机构信息

Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.

Department of Earth, Environmental and Planetary Science, Rice University, Houston, Texas.

出版信息

Am J Perinatol. 2023 Apr;40(5):461-466. doi: 10.1055/a-1904-9279. Epub 2022 Jul 20.

Abstract

OBJECTIVE

The international consensus on continuous glucose monitoring (CGM) recommends time in range (TIR) target of >70% for pregnant people. Our aim was to compare outcomes between pregnant people with TIR ≤ versus >70%.

STUDY DESIGN

This study was a retrospective study of all people using CGM during pregnancy from January 2017 to May 2021 at a tertiary care center. All people with pregestational diabetes who used CGM and delivered at our center were included in the analysis. Primary neonatal outcome included any of the following: large for gestational age, neonatal intensive care unit (NICU) admission, need for intravenous (IV) glucose, or respiratory distress syndrome (RDS). Maternal outcomes included hypertensive disorders of pregnancy and delivery outcomes. Logistic regression was used to estimate unadjusted and adjusted odds ratios (aORs) with 95% confidence intervals (CIs).

RESULTS

Of 78 people managed with CGM, 65 (80%) met inclusion criteria. While 33 people (50.1%) had TIR ≤70%, 32 (49.2%) had TIR >70%. People with TIR ≤70% were more likely to be younger, have a lower body mass index, and have type 1 diabetes than those with TIR >70%. After multivariable regression, there was no difference in the composite neonatal outcome between the groups (aOR: 0.56, 95% CI: 0.16-1.92). However, neonates of people with TIR ≤70% were more likely to be admitted to the NICU ( = 0.035), to receive IV glucose ( = 0.005), to have RDS ( = 0.012), and had a longer hospital stay ( = 0.012) compared with people with TIR >70%. Furthermore, people with TIR ≤70% were more likely to develop hypertensive disorders ( = 0.04) than those with TIR >70%.

CONCLUSION

In this cohort, the target of TIR >70% was reached in about one out of two people with diabetes using CGM, which correlated with a reduction in neonatal and maternal complications.

KEY POINTS

· Among people with diabetes, 50% reached the recommended time in range using CGM.. · Time in range >70% was associated with reducing the rate of some neonatal complications.. · Time in range ≤70% was associated with increased risk for adverse maternal outcomes..

摘要

目的

连续血糖监测(CGM)的国际共识建议,孕妇血糖在目标范围内(TIR)的时间应超过70%。我们的目的是比较TIR≤70%与TIR>70%的孕妇的结局。

研究设计

本研究是一项回顾性研究,研究对象为2017年1月至2021年5月在一家三级医疗中心孕期使用CGM的所有孕妇。所有孕期使用CGM并在我们中心分娩的孕前糖尿病患者均纳入分析。主要新生儿结局包括以下任何一项:大于胎龄儿、新生儿重症监护病房(NICU)入院、需要静脉输注葡萄糖或呼吸窘迫综合征(RDS)。母体结局包括妊娠高血压疾病和分娩结局。采用逻辑回归估计未调整和调整后的比值比(aOR)及95%置信区间(CI)。

结果

在78例接受CGM管理的孕妇中,65例(80%)符合纳入标准。其中33例(50.1%)TIR≤70%,32例(49.2%)TIR>70%。与TIR>70%的孕妇相比,TIR≤70%的孕妇更年轻,体重指数更低,且患1型糖尿病的比例更高。多变量回归分析后,两组间复合新生儿结局无差异(aOR:0.56,95%CI:0.16 - 1.92)。然而,与TIR>70%的孕妇相比,TIR≤70%的孕妇的新生儿更易入住NICU(P = 0.035),更易接受静脉输注葡萄糖(P = 0.005),更易发生RDS(P = 0.012),住院时间更长(P = 0.012)。此外,与TIR>70%的孕妇相比,TIR≤70%的孕妇更易发生高血压疾病(P = 0.04)。

结论

在该队列中,约二分之一使用CGM的糖尿病孕妇达到了TIR>70%的目标,这与新生儿和母体并发症的减少相关。

关键点

· 在糖尿病孕妇中,50%使用CGM达到了推荐的血糖在目标范围内的时间。· 血糖在目标范围内的时间>70%与某些新生儿并发症发生率的降低相关。· 血糖在目标范围内的时间≤70%与不良母体结局风险增加相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验